Home » Topics » BioWorld Science

BioWorld Science
RSS

SQZ-PBMC-HPV begins phase I study in HPV+ recurrent, locally advanced or metastatic solid tumors

Nov. 14, 2019

Pivotal study of Nucala in hypereosinophilic syndrome meets primary endpoint

Nov. 14, 2019

Phase IIa study of THX-110 in obstructive sleep apnea meets primary endpoint

Nov. 14, 2019

Bacteriophage "cocktail" fights drinking sequelae, PSC

Nov. 14, 2019

Phase I/II study of DF-1001 in advanced HER2-expressing sold tumors begins dosing

Nov. 14, 2019

Sichuan Kelun-Biotech Biopharmaceutical identifies new arginase-1 inhibitors

Nov. 14, 2019

Shanghai Leadopharma Technology presents antiepileptic compounds

Nov. 14, 2019

Sumitomo Dainippon Pharma patents mGlu2 receptor negative allosteric modulators

Nov. 14, 2019

AlaMab Therapeutics discloses connexin-43 antibodies

Nov. 14, 2019

KINE-101, a novel synthetic peptide for rheumatoid arthritis

Nov. 14, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...